Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

China first to approve AstraZeneca, FibroGen anaemia drug

December 18, 2018 11:20 AM
126 0

LONDON (Reuters) - China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.

Despite the early win, the two partners said on Tuesday they did not expect to launch roxadustat in China until the second half of 2019.

Read more

Share in social networks:

Comments - 0